Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs.
oleh: Geraint Davies, Martin Boeree, Dave Hermann, Michael Hoelscher
| Format: | Article |
|---|---|
| Diterbitkan: | Public Library of Science (PLoS) 2019-07-01 |
Deskripsi
Geraint Davies and colleagues discuss the potential for innovative early-phase clinical trial methods and technologies to reduce risk and speed up drug development for tuberculosis.